Elevated levels of regulatory T cells predicted time progression in some CLLs

December 2010
Hem/Onc Today;12/25/2010, Vol. 11 Issue 24, p17
The article discusses a study which revealed faster progress to treatment among patients with low- to intermediate-stage chronic lymphocytic leukemia when they had higher levels of regulatory T cells.


Related Articles

  • Phenotypic transformation of CD52pos to CD52neg leukemic T cells as a mechanism for resistance to CAMPATH-1H. Birhiray, R E; Shaw, G; Guldan, S; Rudolf, D; Delmastro, D; Santabarbara, P; Brettman, L // Leukemia (08876924);May2002, Vol. 16 Issue 5, p861 

    Immunotherapy utilizing CAMPATH-1H for patients with chemotherapy-refractory chronic lymphocytic leukemia has yielded encouraging results with many reports of complete remission. Here we report the outcome of two patients with CD4-positive T cell prolymphocytic leukemia treated with CAM-PATH-1H....

  • Inhibition of T cell/B cell interaction by B-CLL cells. Kneitz, C; Goller, M; Wilhelm, M; Mehringer, C; Wohlleben, G; Schimpl, A; Tony, H-P // Leukemia (08876924);Jan99, Vol. 13 Issue 1, p98 

    The course of disease in patients suffering from chronic lymphocytic leukemia (CLL) is determined by a profound dysregulation of the immune system. The resulting immune suppression is the main cause of death in those patients. In the present study we addressed the question of whether leukemic B...

  • Deletion analysis of chromosome 13q14.3 and characterisation of an alternative splice form LEU1 in B cell chronic lymphocytic leukemia. Rowntree, C.; Duke, V.; Panayiotidis, P.; Kotsi, P.; Palmisano, G.L.; Hoffbrand, A.V.; Foroni, L. // Leukemia (08876924);Jul2002, Vol. 16 Issue 7, p1267 

    Heterozygous and homozygous deletions of chromosome 13q14.3 are found in 50% of patients with B cell CLL, suggestIng the presence of one or more tumour suppressor genes within the deleted region. To identify candidate genes from the region, we constructed a map of 13q14.3 using a combination of...

  • B-CLL cells are capable of synthesis and secretion of both pro- and anti-angiogenic molecules. Kay, N E; Bone, N D; Tschumper, R C; Howell, K H; Geyer, S M; Dewald, G W; Hanson, C A; Jelinek, D F // Leukemia (08876924);May2002, Vol. 16 Issue 5, p911 

    Initial work has shown that clonal B cells from B-chronic lymphocytic leukemia (B-CLL) are able to synthesize pro-angiogenic molecules. In this study, our goal was to study the spectrum of angiogenic factors and receptors expressed in the CLL B cell. We used ELISA assays to determine the levels...

  • Identification of three subgroups of B cell chronic lymphocytic leukemia based upon mutations of BCL-6 and IgV genes. Capello, D; Fais, F; Vivenza, D; Migliaretti, G; Chiorazzi, N; Gaidano, G; Ferrarini, M // Leukemia (08876924);May2000, Vol. 14 Issue 5, p811 

    Although B cell chronic lymphocytic leukemia (B-CLL) has been traditionally viewed as a tumor of virgin B cells, this notion has been recently questioned by data suggesting that a fraction of B-CLL derives from antigen experienced B cells. In order to further clarify the histogenetic derivation...

  • Targeting proliferation of chronic lymphocytic leukemia (CLL) cells through KCa3.1 blockade. Grössinger, E M; Weiss, L; Zierler, S; Rebhandl, S; Krenn, P W; Hinterseer, E; Schmölzer, J; Asslaber, D; Hainzl, S; Neureiter, D; Egle, A; Piñón-Hofbauer, J; Hartmann, T N; Greil, R; Kerschbaum, H H // Leukemia (08876924);Apr2014, Vol. 28 Issue 4, p954 

    A letter to the editor is presented regarding proliferation of chronic lymphocytic leukemia (CLL) cells via KCa3.1 blockade.

  • Diagnosis and treatment of chronic lymphocytic leukemia: recommendations from the Brazilian Group of Chronic Lymphocytic Leukemia. Arrais Rodrigues, Celso; Vescovi Gonçalves, Matheus; Valério Ikoma, Maura Rosane; Lorand-Metze, Irene; Domingues Pereira, André; de Farias, Danielle Leão Cordeiro; de Lourdes Lopes Ferrari Chauffaille, Maria; Schaffel, Rony; Oliveira Ribeiro, Eduardo Flávio; da Rocha, Talita Silveira; Buccheri, Valeria; Vasconcelos, Yuri; de Piratininga Figueiredo, Vera Lúcia; Sérgio Chiattone, Carlos; Mihoko Yamamoto // Revista Brasileira de Hematologia e Hemoterapia;out-dez2016, Vol. 38 Issue 4, p346 

    Chronic lymphocytic leukemia is characterized by clonal proliferation and progressive accumulation of B-cell lymphocytes that typically express CD19+, CD5+ and CD23+. The lymphocytes usually infiltrate the bone marrow, peripheral blood, lymph nodes, and spleen. The diagnosis is established by...

  • Why not work on T and NK cells in the Kunkel laboratory? Kabelitz, D // Lupus;2003, Vol. 12 Issue 3, p195 

    Coming from Hans Wigzell's laboratory in Uppsala, Sweden, I joined the Kunkel laboratory in 1981 to spend a post-doctoral fellowship period financed by the German Research Organization. While I initially worked with Nick Chiorazzi in an attempt to generate monoclonal antibody-secreting human...

  • Differential adhesion pattern of B cell chronic lymphocytic leukemia cells. Behr, S I; Korinth, D; Schriever, F // Leukemia (08876924);Jan98, Vol. 12 Issue 1, p71 

    Binding of B cell chronic lymphocytic leukemia (B-CLL) cells to other cells and to extracellular matrices influences the pathophysiology and the clinical presentation of the B-CLL disease. It is still unknown which adhesion pathways regulate the traffic of B-CLL cells within distinct histologic...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics